RASopathy: genes and variants

Explore variant evidence for RASopathy across 13 analyzed proteins (PTPN11, BRAF, RAF1, KRAS, SOS1 and 8 more). Linked ClinVar records include 212 pathogenic or likely pathogenic variants, 2,235 variants of uncertain significance and 257 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to RASopathy

Weakly linked (only a few uncertain records): DDC.

Where RASopathy variants cluster

ClinVar pathogenic and likely pathogenic variants linked to RASopathy

VariantPositionProtein partClinical label
HRAS A59G59Pathogenic / likely pathogenic (★★★★)
MAP2K2 Y134C134Protein kinasePathogenic / likely pathogenic (★★★)
MAP2K2 Y134H134Protein kinasePathogenic / likely pathogenic (★★★)
PTPN11 Y279C279Tyrosine-protein phosphatasePathogenic / likely pathogenic (★★★)
HRAS A59L59Pathogenic / likely pathogenic (★★★)
HRAS A59T59Pathogenic / likely pathogenic (★★★)
SOS2 M267K267DHPathogenic / likely pathogenic (★★★)
BRAF T241K241Phorbol-ester/DAG-typePathogenic / likely pathogenic (★★★)
BRAF G464E464Protein kinasePathogenic / likely pathogenic (★★★)
BRAF L485S485Protein kinasePathogenic / likely pathogenic (★★★)
BRAF L485F485Protein kinasePathogenic / likely pathogenic (★★★)
BRAF T599I599Protein kinasePathogenic / likely pathogenic (★★★)
BRAF T599R599Protein kinasePathogenic / likely pathogenic (★★★)
HRAS T58I58Pathogenic / likely pathogenic (★★★)
KRAS K5N5Pathogenic / likely pathogenic (★★★)
KRAS V14I14Pathogenic / likely pathogenic (★★★)
KRAS Q22R22Pathogenic / likely pathogenic (★★★)
NRAS G12S12Pathogenic / likely pathogenic (★★★)
NRAS G60E60Pathogenic / likely pathogenic (★★★)
PTPN11 T52I52SH2 1Pathogenic / likely pathogenic (★★★)
PTPN11 Y62D62SH2 1Pathogenic / likely pathogenic (★★★)
PTPN11 E69Q69SH2 1Pathogenic / likely pathogenic (★★★)
PTPN11 L261F261Tyrosine-protein phosphatasePathogenic / likely pathogenic (★★★)
PTPN11 L261H261Tyrosine-protein phosphatasePathogenic / likely pathogenic (★★★)
PTPN11 A461G461Tyrosine-protein phosphatasePathogenic / likely pathogenic (★★★)
PTPN11 A461V461Tyrosine-protein phosphatasePathogenic / likely pathogenic (★★★)
PTPN11 A461T461Tyrosine-protein phosphatasePathogenic / likely pathogenic (★★★)
PTPN11 Q510P510Tyrosine-protein phosphatasePathogenic / likely pathogenic (★★★)
PTPN11 Q510H510Tyrosine-protein phosphatasePathogenic / likely pathogenic (★★★)
RAF1 R256S256Pathogenic / likely pathogenic (★★★)
RAF1 S257P257Pathogenic / likely pathogenic (★★★)
RAF1 S259Y259Pathogenic / likely pathogenic (★★★)
RAF1 S259A259Pathogenic / likely pathogenic (★★★)
RAF1 S259T259Pathogenic / likely pathogenic (★★★)
RAF1 V263G263Pathogenic / likely pathogenic (★★★)
PTPN11 K70R70SH2 1Pathogenic / likely pathogenic (★★★)
PTPN11 R265Q265Tyrosine-protein phosphatasePathogenic / likely pathogenic (★★★)
RIT1 M90V90Pathogenic / likely pathogenic (★★★)
BRAF G265R265Phorbol-ester/DAG-typePathogenic / likely pathogenic (★★★)
BRAF G469E469Protein kinasePathogenic / likely pathogenic (★★★)
BRAF C532Y532Protein kinasePathogenic / likely pathogenic (★★★)
BRAF D594V594Protein kinasePathogenic / likely pathogenic (★★★)
BRAF F595L595Protein kinasePathogenic / likely pathogenic (★★★)
BRAF G596V596Protein kinasePathogenic / likely pathogenic (★★★)
BRAF V600G600Protein kinasePathogenic / likely pathogenic (★★★)
KRAS S65I65Pathogenic / likely pathogenic (★★★)
MAP2K1 L42R42Pathogenic / likely pathogenic (★★★)
MAP2K1 L42F42Pathogenic / likely pathogenic (★★★)
MAP2K1 N122D122Protein kinasePathogenic / likely pathogenic (★★★)
PTPN11 G464A464Tyrosine-protein phosphatasePathogenic / likely pathogenic (★★★)
PTPN11 Q506P506Tyrosine-protein phosphatasePathogenic / likely pathogenic (★★★)
RAF1 T491I491Protein kinasePathogenic / likely pathogenic (★★★)
SOS1 R552S552Pathogenic / likely pathogenic (★★★)
HRAS K117R117Pathogenic / likely pathogenic (★★★)
NRAS I24N24Pathogenic / likely pathogenic (★★★)
NRAS T50I50Pathogenic / likely pathogenic (★★★)
BRAF F635L635Protein kinasePathogenic / likely pathogenic (★★★)
MAP2K1 F53S53Pathogenic / likely pathogenic (★★★)
MAP2K1 K57Q57Pathogenic / likely pathogenic (★★★)
MAP2K1 L92R92Protein kinasePathogenic / likely pathogenic (★★★)

Showing 60 of 212.

Uncertain variants prioritized for review in RASopathy

VariantPositionProtein partClinical labelEvidence
CBL R420P420RING-typeConflicting reports (★)+7: 2 other pathogenic changes within 3 positions; R420L at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.872
CBL H398R398RING-typeConflicting reports (★)+7: in a 3D region that tolerates change poorly (3R); H398N at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.951
SOS1 M269V269DHConflicting reports (★)+7: 4 other pathogenic changes within 3 positions; M269R at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.788
CBL H398Y398RING-typeConflicting reports (★)+7: in a 3D region that tolerates change poorly (3R); H398N at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.943
CBL R420G420RING-typeUncertain (★)+7: 2 other pathogenic changes within 3 positions; R420L at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.955
SOS1 K728Q728N-terminal Ras-GEFUncertain (★)+6: 2 other pathogenic changes within 3 positions; K728I at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98
MAP2K1 R108Q108Protein kinaseUncertain (★★)+6: 2 other pathogenic changes within 3 positions; R108L at the same position is pathogenic; seen in 7.5e-06 of gnomAD DNA copies; REVEL 0.728
MAP2K2 V64A64Uncertain (★★)+6: 3 other pathogenic changes within 3 positions; V64F at the same position is pathogenic; seen in 7.5e-06 of gnomAD DNA copies; REVEL 0.717
MAP2K2 Y134F134Protein kinaseUncertain (★)+6: 3 other pathogenic changes within 3 positions; Y134C at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.704
SOS1 K728T728N-terminal Ras-GEFUncertain (★★)+6: 2 other pathogenic changes within 3 positions; K728I at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99
MAP2K1 N122H122Protein kinaseUncertain (★)+6: 3 other pathogenic changes within 3 positions; N122D at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.654

Which prediction tools work for RASopathy

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to RASopathy

Frequently asked questions

Which genes have records linked to RASopathy?

This view contains 13 analyzed proteins: PTPN11, BRAF, RAF1, KRAS, SOS1 and 8 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 212 pathogenic or likely pathogenic variants, 2,235 variants of uncertain significance and 257 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 11 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 2,917 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center